lomefloxacin has been researched along with pefloxacin in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.04) | 18.7374 |
| 1990's | 11 (47.83) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Antón-Fos, GM; Duart, MJ; Mut-Ronda, S; Salabert-Salvador, MT | 1 |
| Baroni, M; Cecchetti, V; Cianchetta, G; Cruciani, G; Mannhold, R | 1 |
| Avdeef, A; Sun, N; Tam, KY; Tsinman, O | 1 |
| Hannan, A | 1 |
| Gelber, RH; Iranmanesh, A; Murray, L; Siu, P; Tsang, M | 1 |
| Borsa-Lebas, F; Dhib, M; Fillastre, JP; Humbert, G; Leroy, A; Moulin, B | 1 |
| Glupczynski, Y; Grenier, P; Pierard, D; Van der Auwera, P | 1 |
| Courvalin, P; Derlot, E; Poyart-Salmeron, C | 1 |
| Fernandes, PB; Swanson, RN | 1 |
| Davidson, RJ; Drobot, GR; Hoban, DJ; Karlowsky, JA; Philips, R; Zhanel, GG | 1 |
| D'iakov, SI; Katsalukha, VV; Lebedeva, IK; Lukashina, AV; Raĭskaia, VA | 1 |
| Croizé, J; Le Noc, D; Le Noc, P | 1 |
| Iakovlev, SV; Iakovlev, VP; Izotova, GN | 1 |
| Capron, MH; Giacomino, A; Guibert, J | 1 |
| Anan'eva, LP; Belov, BS; Nasonova, VA; Shubin, SV; Soldatova, SI; Tarasova, GM; Urumova, MM; Ushakova, MA | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| Baumann-Wilschke, I; Förster, C; Rücker, M; Shakibaei, M; Stahlmann, R; Vormann, J | 1 |
| Kassab, NM; Kedor-Hackmam, ER; Santoro, MI; Singh, AK | 1 |
| Andreeva, I; Rafalsky, V; Rjabkova, E | 1 |
| Chen, X; Hua, H; Ji, C; Lin, X; Liu, Y; Tang, S; Yue, Z | 1 |
| Chen, P; Sun, H; Wang, F; Wen, H | 1 |
| Ding, F; Ding, YU; Liu, D; Sha, L; Tang, X; Xu, Y | 1 |
3 review(s) available for lomefloxacin and pefloxacin
| Article | Year |
|---|---|
Pharmacokinetics of quinolones in renal insufficiency.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Glomerular Filtration Rate; Half-Life; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1990 |
[Pharmacokinetics of fluoroquinolones in patients with renal insufficiency].
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Ofloxacin; Pefloxacin; Quinolones; Renal Insufficiency | 1995 |
Quinolones for uncomplicated acute cystitis in women.
Topics: Acute Disease; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Female; Fluoroquinolones; Humans; Levofloxacin; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Randomized Controlled Trials as Topic | 2006 |
1 trial(s) available for lomefloxacin and pefloxacin
| Article | Year |
|---|---|
[Treatment of non-complicated acute cystitis in women: lomefloxacin versus pefloxacin].
Topics: Acute Disease; Adult; Anti-Infective Agents; Cystitis; Family Practice; Female; Fluoroquinolones; Humans; Middle Aged; Pefloxacin; Quinolones | 1996 |
19 other study(ies) available for lomefloxacin and pefloxacin
| Article | Year |
|---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Search compounds with antimicrobial activity by applying molecular topology to selected quinolones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Discriminant Analysis; Drug Design; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones | 2003 |
Chemometric studies on the bactericidal activity of quinolones via an extended VolSurf approach.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Escherichia coli; Models, Molecular; Pseudomonas aeruginosa; Quantitative Structure-Activity Relationship; Quinolones; Staphylococcus aureus; Thermodynamics | 2004 |
The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
Topics: Caco-2 Cells; Cell Membrane Permeability; Humans; Hydrogen-Ion Concentration; Membranes, Artificial; Molecular Structure; Pharmaceutical Preparations | 2010 |
Comparative in vitro activity of enoxacin and other fluoroquinolones against multi-resistant strains of Salmonella typhi.
Topics: Ampicillin; Anti-Infective Agents; Chloramphenicol; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolones; Salmonella typhi; Species Specificity; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1992 |
Activities of various quinolone antibiotics against Mycobacterium leprae in infected mice.
Topics: Animals; Anti-Infective Agents; Female; Fluoroquinolones; Leprosy; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Pefloxacin; Quinolones | 1992 |
In-vitro activity of lomefloxacin in comparison with pefloxacin and ofloxacin.
Topics: Aeromonas; Anti-Infective Agents; Campylobacter; Corynebacterium; Enterobacteriaceae; Fluoroquinolones; Haemophilus; Neisseria gonorrhoeae; Ofloxacin; Pefloxacin; Quinolones; Staphylococcus aureus | 1989 |
Antibacterial and plasmid curing activity of lomefloxacin in vitro.
Topics: Anti-Infective Agents; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Plasmids; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus | 1989 |
Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1988 |
The accumulation of fluoroquinolones in Staphylococcus aureus during the postantibiotic effect.
Topics: Anti-Infective Agents; Biotransformation; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolones; Staphylococcus aureus | 1994 |
[Comparative evaluation of the effectiveness of fluoroquinolones in experimental anthrax infection].
Topics: Animals; Anthrax; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Evaluation Studies as Topic; Fluoroquinolones; Lethal Dose 50; Mice; Microbial Sensitivity Tests; Pefloxacin; Quinolones | 1994 |
[Compared antibacterial activity of a new fluoroquinolone, sparfloxacin (AT 4140, RP 64206) and four other fluoroquinolones against 332 strains of enteropathogen bacteria].
Topics: Anti-Infective Agents; Campylobacter jejuni; Ciprofloxacin; Dose-Response Relationship, Drug; Escherichia coli; Fluoroquinolones; Helicobacter pylori; Humans; In Vitro Techniques; Ofloxacin; Pefloxacin; Quinolones; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica | 1993 |
[Use of fluoroquinolones in rheumatology].
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Drug Tolerance; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Middle Aged; Pefloxacin; Quinolones; Rheumatic Diseases; Time Factors | 1996 |
In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pefloxacin; Quinolones; Respiratory Tract Infections | 1997 |
Effects of fluoroquinolones and magnesium deficiency in murine limb bud cultures.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Embryo, Mammalian; Embryonic and Fetal Development; Extremities; Fleroxacin; Fluoroquinolones; Magnesium Deficiency; Mice; Microscopy, Electron; Ofloxacin; Pefloxacin; Quinolones | 1998 |
Quantitative determination of gatifloxacin, levofloxacin, lomefloxacin and pefloxacin fluoroquinolonic antibiotics in pharmaceutical preparations by high-performance liquid chromatography.
Topics: Anti-Bacterial Agents; Calibration; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Ethylamines; Fluoroquinolones; Gatifloxacin; Hydrogen-Ion Concentration; Levofloxacin; Models, Chemical; Models, Statistical; Ofloxacin; Pefloxacin; Pharmaceutical Preparations; Quinolones; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tablets; Temperature; Time Factors | 2006 |
[Determination of 16 quinolone residues in animal tissues using high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry].
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Enrofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2007 |
Investigation on enhanced chemiluminescence reaction systems with bis(hydrogenperiodato) argentate(III) complex anion for fluoroquinolones synthetic antibiotics.
Topics: Anti-Bacterial Agents; Enrofloxacin; Fluoroquinolones; Luminescence; Methods; Organometallic Compounds; Pefloxacin; Periodic Acid; Silver | 2009 |
Detection and Quantitation of Lomefloxacin and Pefloxacin Residues in the Organ Tissues and Eggs of Laying Hens.
Topics: Animals; Anti-Bacterial Agents; Chickens; China; Drug Residues; Eggs; Female; Fluoroquinolones; Organ Specificity; Pefloxacin | 2018 |